Overview
Melanoma cells are malignant cells that arise from melanocytes, the neural-crest-derived, pigment-producing cells located in the basal layer of the epidermis, the uveal tract, and mucosal surfaces. Their transformation is driven by accumulated genomic alterations, frequently involving constitutive activation of the MAPK signalling pathway through mutations in BRAF, NRAS, or NF1, alongside changes in regulators such as the Smoothened component of Hedgehog signalling. These lesions confer uncontrolled proliferation, loss of contact inhibition, and a strong propensity for early dermal invasion and distant metastasis, making melanoma among the more biologically aggressive cutaneous and non-cutaneous malignancies. Research on melanoma cells examines how their growth properties evolve under different experimental conditions, including the behaviour of solid tumour cells in vitro and across model systems used to study invasion and drug response. Because melanoma cells are highly immunogenic yet adept at evading immune surveillance, much work centres on therapeutic strategies that exploit this biology, including immune checkpoint modulation and the combination of radiation therapy with immunotherapy to enhance tumour control. Studies also document rare presentations, such as melanoma at unusual anatomical sites, underscoring the heterogeneity of melanoma cell phenotypes and the continuing need to characterise their molecular, proliferative, and metastatic determinants.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Melanoma of the Breast with Smoothened (SMO) Mutation: Case Report and review of the Literature
Combination of Radiation Therapy and Immunotherapy in the Treatment of Melanoma
Avant Garde Alleviation -Cancer Immunotherapy
Syndrome of inappropriate antidiuretic hormone secretion in a patient with a Nodular Lymphocyte-Predominant Hodgkin Lymphoma. A case report and review of literature
Extraosseous Plasmacytoma of Thyroid Arising in Hashimoto’s Thyroiditis
How this research is being cited
The 6 articles above have been cited 13 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · Expert Opinion on Drug Safety
-
2024 · Expert Opinion on Drug Safety
-
2023 · Siberian Journal of Oncology
-
2023 · Siberian journal of oncology
-
2022 · Effective Pharmacotherapy
-
2022 · Head and Neck Pathology
-
2022 · Head and Neck Pathology
-
B. Ellerin et al. · 2020 · Cancer Radiothérapie
A sample of recent works citing this journal's research on Melanoma Cells, linking to each citing work.